Bmi1 Resistance Pathway and Immune Checkpoint Blockade in Lung Cancer

被引：0
|
作者：
Chaudhary, K. R. [1 ]
Halmos, B. [2 ,3 ]
Cheng, H. [2 ,3 ]
Cheng, S. K. [1 ,4 ]
机构：
[1] Columbia Univ, Irving Med Ctr, Dept Radiat Oncol, New York, NY USA
[2] Albert Einstein Coll Med, Dept Oncol, Bronx, NY 10467 USA
[3] Montefiore Med Ctr, 111 E 210th St, Bronx, NY 10467 USA
[4] Columbia Univ, Irving Med Ctr, Herbert Irving Comprehens Canc Ctr, New York, NY USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2021年 / 111卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2893
引用
收藏
页码：E432 / E433
页数：2
相关论文
共 50 条
  • [1] Strategies to overcome resistance to immune checkpoint blockade in lung cancer
    Attili, Ilaria
    Tarantino, Paolo
    Passaro, Antonio
    Stati, Valeria
    Curigliano, Giuseppe
    de Marinis, Filippo
    [J]. LUNG CANCER, 2021, 154 : 151 - 160
  • [2] Immune Checkpoint Blockade in Lung Cancer
    Somasundaram, Aswin
    Socinski, Mark A.
    Villaruz, Liza C.
    [J]. DISCOVERY MEDICINE, 2016, 22 (119) : 56 - 66
  • [3] Proliferative potential and resistance to immune checkpoint blockade in lung cancer patients
    Pabla, Sarabjot
    Conroy, Jeffrey M.
    Nesline, Mary K.
    Glenn, Sean T.
    Papanicolau-Sengos, Antonios
    Burgher, Blake
    Hagen, Jacob
    Giamo, Vincent
    Andreas, Jonathan
    Lenzo, Felicia L.
    Wang Yirong
    Dy, Grace K.
    Yau, Edwin
    Early, Amy
    Chen, Hongbin
    Bshara, Wiam
    Madden, Katherine G.
    Shirai, Keisuke
    Dragnev, Konstantin
    Tafe, Laura J.
    Marin, Daniele
    Zhu, Jason
    Clarke, Jeff
    Labriola, Matthew
    McCall, Shannon
    Zhang, Tian
    Zibelman, Matthew
    Ghatalia, Pooja
    Araujo-Fernandez, Isabel
    Singavi, Arun
    George, Ben
    MacKinnon, Andrew Craig
    Thompson, Jonathan
    Singh, Rajbir
    Jacob, Robin
    Dressler, Lynn
    Steciuk, Mark
    Binns, Oliver
    Kasuganti, Deepa
    Shah, Neel
    Ernstoff, Marc
    Odunsi, Kunle
    Kurzrock, Razelle
    Gardner, Mark
    Galluzzi, Lorenzo
    Morrison, Carl
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [4] Cancer: BMI1 inhibition reverses lung cancer
    Crunkhorn S.
    [J]. Nature Reviews Drug Discovery, 2016, 15 (10) : 678 - 678
  • [5] Immune checkpoint blockade resistance in lung cancer: emerging mechanisms and therapeutic opportunities
    Konen, Jessica M.
    Wu, Haoyi
    Gibbons, Don L.
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2024, 45 (06) : 520 - 536
  • [6] Immune checkpoint blockade for lung cancer: state of the art
    Patel, Sandip Pravin
    [J]. TRANSLATIONAL CANCER RESEARCH, 2015, 4 (04) : 415 - 422
  • [7] Immune checkpoint blockade in small cell lung cancer
    Tay, Rebecca Y.
    Heigener, David
    Reck, Martin
    Califano, Raffaele
    [J]. LUNG CANCER, 2019, 137 : 31 - 37
  • [8] Primary and adaptive resistance to checkpoint blockade in lung cancer
    Hammerman, Peter
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (02) : S6 - S7
  • [9] Immune Checkpoint Blockade: The Hope for Immunotherapy as a Treatment of Lung Cancer?
    Brahmer, Julie R.
    [J]. SEMINARS IN ONCOLOGY, 2014, 41 (01) : 126 - 132
  • [10] Prognostic Signature of Response to PD-1 Immune Checkpoint Blockade in Lung Cancer
    Ding, Juan
    Sun, Tingting
    Yao, Juan
    Zheng, Ni
    Lu, Rong
    [J]. JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2023, 37 (02): : 617 - 628
12345